Extraintestinal manifestations in inflammatory bowel disease

被引:238
作者
Danese, Silvio [1 ]
Semeraro, Stefano [1 ]
Papa, Alfredo [1 ]
Roberto, Italia [1 ]
Scaldaferri, Franco [1 ]
Fedeli, Giuseppe [1 ]
Gasbarrini, Giovanni [1 ]
Gasbarrini, Antonio [1 ]
机构
[1] Catholic Univ Sch Med, Dept Internal Med, I-00168 Rome, Italy
关键词
Crohn's disease; Ulcerative colitis; Inflammatory bowel disease;
D O I
10.3748/wjg.v11.i46.7227
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Inflammatory bowel diseases (IBD) can be really considered to be systemic diseases since they are often associated with extraintestinal manifestations, complications, and other autoimmune disorders. Indeed, physicians who care for patients with ulcerative colitis and Crohn's disease, the two major forms of IBD, face a new clinical challenge every day, worsened by the very frequent rate of extraintestinal complications. The goal of this review is to provide an overview and an update on the extraintestinal complications occurring in IBD. Indeed, this paper highlights how virtually almost every organ system can be involved, principally eyes, skin, joints, kidneys, liver and biliary tracts, and vasculature (or vascular system) are the most common sites of systemic IBD and their involvement is dependent on different mechanisms. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:7227 / 7236
页数:10
相关论文
共 118 条
  • [101] IgA antiglomerular basement membrane nephritis associated with Crohn's disease: A case report and review of glomerulonephritis in inflammatory bowel disease
    Shaer, AJ
    Stewart, LR
    Cheek, DE
    Hurray, D
    Self, SE
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (05) : 1097 - 1109
  • [102] Venous thromboembolism in inflammatory bowel disease
    Solem, CA
    Loftus, EV
    Tremaine, WJ
    Sandborn, WJ
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (01) : 97 - 101
  • [103] Solem CA, 2002, AM J GASTROENTEROL, V97, P2300
  • [104] Comparative tolerability of treatments for inflammatory bowel disease
    Stein, RB
    Hanauer, SB
    [J]. DRUG SAFETY, 2000, 23 (05) : 429 - 448
  • [105] Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease
    Stockbrügger, RW
    Schoon, EJ
    Bollani, S
    Mills, PR
    Israeli, E
    Landgraf, L
    Felsenberg, D
    Ljunghall, S
    Nygard, G
    Persson, T
    Graffner, H
    Porro, GB
    Ferguson, A
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (08) : 1519 - 1527
  • [106] VASCULAR COMPLICATIONS OF INFLAMMATORY BOWEL-DISEASE
    TALBOT, RW
    HEPPELL, J
    DOZOIS, RR
    BEART, RW
    [J]. MAYO CLINIC PROCEEDINGS, 1986, 61 (02) : 140 - 145
  • [107] Primary sclerosing cholangitis
    Talwalkar, JA
    Lindor, KD
    [J]. INFLAMMATORY BOWEL DISEASES, 2005, 11 (01) : 62 - 72
  • [108] THE GERM-FREE STATE PREVENTS DEVELOPMENT OF GUT AND JOINT INFLAMMATORY DISEASE IN HLA-B27 TRANSGENIC RATS
    TAUROG, JD
    RICHARDSON, JA
    CROFT, JT
    SIMMONS, WA
    ZHOU, M
    FERNANDEZSUEIRO, JL
    BALISH, E
    HAMMER, RE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) : 2359 - 2364
  • [109] Crohn's disease associated with spondyloarthropathy:: effect of TNF-α blockade with infliximab on articular symptoms
    Van den Bosch, F
    Kruithof, E
    De Vos, M
    De Keyser, F
    Mielants, H
    [J]. LANCET, 2000, 356 (9244) : 1821 - 1822
  • [110] Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: A randomized double-blind pilot study
    van Hoogstraten, HJF
    Vleggaar, FP
    Boland, GJ
    van Steenbergen, W
    Griffioen, P
    Hop, WCJ
    van Hattum, J
    Henegouwen, GPV
    Schalm, SW
    van Buuren, HR
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (08) : 2015 - 2022